Experiment 1231313

Details

PropertyValue
Pharmacology
Administration routeIM
OrganismChelidonium majus (PAPAVERACEAE)
CitationDANYSZ,A: KOKOSCHINEGG,M: HAMLER,F:. (1992). CLINICAL STUDIES OF UKRAIN IN HEALTHY VOLUNTEERS (PHASE 1).. 18()
Amount utilized
Compound isolated
DiseaseEXTRACT GIVEN IM OR IV EVERY 1-3 DAYS TO 19 HEALTHY VOLUNTEERS FOR 7-40 DAYS (AND IN ONE CASE 3 YRS) IN DOSES OF 5-50 MG. NO CHANGES IN BIOCHEMICAL, HEMATOLOGICAL, IMMUNOLOGICAL, ELECTROLYTES OR TRACE ELEMENT, NEOPTERIN, IMMUNE COMPLEXES OR NON-SPECIFIC BLOCKING FACTORS FOUND.
Dose amountVAR
Number1
Qualitative resultINACTIVE
AnimalHUMAN ADULT
Dose expressionDOSE
ExtractALKALOID FRACT